Evidence map›Paper›PMID 28528221›Full record

Trial reportThe Journal of pediatrics2017

Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study.

Roberta L Keller, Rui Feng, Sara B DeMauro, Thomas Ferkol, William Hardie, Elizabeth E Rogers, Timothy P Stevens, Judith A Voynow, Scarlett L Bellamy, Pamela A Shaw and 2 more

Registry-linked trialOpen access · greenAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in The Journal of pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01435187 (Prematurity and Respiratory Outcomes Program), which is not on this map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
16.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01435187 completednot on this map

Prematurity and Respiratory Outcomes Program (PROP) Core Database Protocol

TypeobservationalSponsorUniversity of PennsylvaniaRan2011 to 2016Enrolled835ConditionsPrematurity, Respiratory Disease
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 200 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Respiratory severity score as a predictor for need for tracheostomy in infants with severe bronchopulmonary dysplasia.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  9. Article
  10. Article
  11. Maternal smoking and CC-16: implications for lung development and COPD across the lifespan.American journal of respiratory and critical care medicine · 2026
    Article
  12. Disparities in delivery hospital risk-adjusted outcomes for very low birthweight infants: the role of NICU volume and level of care.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Article
  13. Interdisciplinary clinical bronchopulmonary dysplasia programs: development, evolution, and maturation.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  14. Review
  15. Review
  16. Review
  17. Sex, hormones, and lung health.Physiological reviews · 2026
    Review
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Roberta L KellerPediatrics/Neonatology, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA. Electronic address: kellerr@peds.ucsf.edu.
Rui FengBiostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA.
Sara B DeMauroPediatrics/Neonatology, University of Pennsylvania, Philadelphia, PA.
Thomas FerkolDepartments of Pediatrics and Cell Biology and Physiology, Washington University, St Louis, MO.
William HardieDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Elizabeth E RogersPediatrics/Neonatology, University of California San Francisco, Benioff Children's Hospital, San Francisco, CA.
Timothy P StevensDepartment of Pediatrics, University of Rochester, Golisano Children's Hospital, Rochester, NY.
Judith A VoynowDepartment of Pediatrics, Virginia Commonwealth University, Richmond, VA.
Scarlett L BellamyBiostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA.
Pamela A ShawBiostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA.
Paul E MooreDepartment of Pediatrics/Pediatric Allergy, Immunology and Pulmonary Medicine and Center for Asthma Research, Vanderbilt University, Nashville, TN.
Prematurity and Respiratory Outcomes Program
University of Pennsylvania · USUniversity of California, San Francisco · USGolisano Children's Hospital · USCincinnati Children's Hospital Medical Center · USVanderbilt University · USVirginia Commonwealth University · USWashington University in St. Louis · US

Funding

Data Coordinating Center for the Prematurity and Respiratory Outcomes ProgramU01HL101794 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SCHMIDT, BARBARA · 2010 to 2014
$10.3M
North Carolina Clinical CenterUG1HD040492 · NICHD · DUKE UNIVERSITY · PI CHARLES Michael COTTEN, Matthew Laughon · 2016 to 2026
$3.4M
Gastrin-Releasing Peptide and Bronchopulmonary DysplasiaR01HL105702 · NHLBI · DUKE UNIVERSITY · PI COTTEN, CHARLES MICHAEL, DAVIS, STEPHANIE DUGGINS · 2011 to 2015
$2.8M
Biomarkers of Immunologic Function and Preterm Respiratory OutcomesU01HL101800 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI CHOUGNET, CLAIRE A., JOBE, ALAN H · 2010 to 2014
$2.5M
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic PreemiesU01HL101813 · NHLBI · UNIVERSITY OF ROCHESTER · PI MARIANI, THOMAS J, PRYHUBER, GLORIA S · 2010 to 2014
$2.4M
Improving Prematurity-related Respiratory Outcomes at Vanderbilt (IMPROV)U01HL101456 · NHLBI · VANDERBILT UNIVERSITY · PI ASCHNER, JUDY LYNN · 2010 to 2014
$2.4M
UCSF Clinical Research Center for Prematurity and Respiratory Outcomes ProgramU01HL101798 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALLARD, PHILIP L., KELLER, ROBERTA L · 2010 to 2014
$2.1M
Influence of the Enteric Microbiome on the Genesis of Bronchopulmonary DysplasiaU01HL101465 · NHLBI · WASHINGTON UNIVERSITY · PI FERKOL, THOMAS W, WARNER, BARBARA B · 2010 to 2014
$2.1M
Graduate Training Program in Neonatal-Perinatal Translational ResearchT32HD071860 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROWITCH, DAVID H · 2012 to 2016
$969k
CD8 T Cell Dysregulation in Premature InfantsK08AI108870 · NIAID · UNIVERSITY OF ROCHESTER · PI SCHEIBLE, KRISTIN · 2014 to 2016
$539k
NHLBI NIH HHS R01 HL105702NHLBI NIH HHS U01 HL101456NHLBI NIH HHS U01 HL101465NHLBI NIH HHS U01 HL101794NHLBI NIH HHS U01 HL101798NHLBI NIH HHS U01 HL101800NHLBI NIH HHS U01 HL101813NIAID NIH HHS K08 AI108870NICHD NIH HHS T32 HD071860NICHD NIH HHS UG1 HD040492
6 · The paper itself

Abstract

objectiveTo assess the utility of clinical predictors of persistent respiratory morbidity in extremely low gestational age newborns (ELGANs). STUDY

designWe enrolled ELGANs (<29 weeks' gestation) at ≤7 postnatal days and collected antenatal and neonatal clinical data through 36 weeks' postmenstrual age. We surveyed caregivers at 3, 6, 9, and 12 months' corrected age to identify postdischarge respiratory morbidity, defined as hospitalization, home support (oxygen, tracheostomy, ventilation), medications, or symptoms (cough/wheeze). Infants were classified as having postprematurity respiratory disease (PRD, the primary study outcome) if respiratory morbidity persisted over ≥2 questionnaires. Infants were classified with severe respiratory morbidity if there were multiple hospitalizations, exposure to systemic steroids or pulmonary vasodilators, home oxygen after 3 months or mechanical ventilation, or symptoms despite inhaled corticosteroids. Mixed-effects models generated with data available at 1 day (perinatal) and 36 weeks' postmenstrual age were assessed for predictive accuracy.

resultsOf 724 infants (918 ± 234 g, 26.7 ± 1.4 weeks' gestational age) classified for the primary outcome, 68.6% had PRD; 245 of 704 (34.8%) were classified as severe. Male sex, intrauterine growth restriction, maternal smoking, race/ethnicity, intubation at birth, and public insurance were retained in perinatal and 36-week models for both PRD and respiratory morbidity severity. The perinatal model accurately predicted PRD (c-statistic 0.858). Neither the 36-week model nor the addition of bronchopulmonary dysplasia to the perinatal model improved accuracy (0.856, 0.860); c-statistic for BPD alone was 0.907.

conclusionBoth bronchopulmonary dysplasia and perinatal clinical data accurately identify ELGANs at risk for persistent and severe respiratory morbidity at 1 year.

trial registrationClinicalTrials.gov: NCT01435187.

Indexed as

Bronchopulmonary DysplasiaCohort StudiesFemaleGestational AgeHealth SurveysHumansInfantInfant, NewbornInfant, Very Low Birth WeightLungMaleMorbidityPregnancyPrognosisProspective Studiesprematuritypulmonary morbiditywheeze

Identifiers

PMID28528221
PMCPMC5533632
OpenAlexW2615043171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.